Oregovomab
- Generic Name
- Oregovomab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 213327-37-8
- Unique Ingredient Identifier
- HX101E7L6S
- Background
Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125.
- Indication
Investigated for use/treatment in ovarian cancer.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath